Literature DB >> 12951311

Peripheral osteoarticular tuberculosis in children: 106 case-reports.

Youssef Teklali1, Zouheir Fellous El Alami, Tarik El Madhi, Hassan Gourinda, Abdelhamid Miri.   

Abstract

INTRODUCTION: We retrospectively reviewed 106 pediatric cases of peripheral osteoarticular tuberculosis (OAT) seen over a 21-year period in Morocco. Patients with vertebral tuberculosis were excluded from the study. PATIENTS AND
RESULTS: The 55 boys and 51 girls had a mean age of 8 years. The hip and knee together contributed 63% of the osteoarticular foci. Organ involvement was documented in 32 cases. Mean time from symptom onset to evaluation was 10 months. This resulted in diagnostic delay, which contributed to the 22% rate of residual abnormalities consisting of joint ankylosis and leg length inequality.
CONCLUSION: OAT is a source of functional disability that should be recognized and treated early, particularly in children, given that appropriate management can lead to a full recovery (14 patients in our series).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951311     DOI: 10.1016/s1297-319x(03)00037-x

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  4 in total

1.  Case 2: The accidental tourist.

Authors:  Sergio Fanella; Leigh Fraser-Roberts
Journal:  Paediatr Child Health       Date:  2008-04       Impact factor: 2.253

2.  Tubercular osteomyelitis of distal ulna presenting as epiphyseal injury.

Authors:  Ranjan Burnwal; Devdatta Suhas Neogi; Surendra Shukla D Ortho
Journal:  Maedica (Buchar)       Date:  2012-09

3.  Isolated tuberculosis of metacarpal bone in a 3 year-old child.

Authors:  El Mouhtadi Aghoutane; Tarik Salama; Redouane El Fezazi
Journal:  Pan Afr Med J       Date:  2017-02-23

4.  Analysis of the early clinical outcomes of arthroscopic debridement in the treatment of shoulder tuberculosis.

Authors:  Yanwei He; Juncai Liu; Zhi Wang; Peng Zhou; Xiangtian Deng; Li Yang; Zan Chen; Zhong Li
Journal:  J Orthop Surg Res       Date:  2020-11-20       Impact factor: 2.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.